{
    "clinical_study": {
        "@rank": "84181", 
        "acronym": "infertility", 
        "arm_group": [
            {
                "arm_group_label": "Group A (Diosmin group)", 
                "arm_group_type": "Active Comparator", 
                "description": "In group A, (Diosmin group),  2 tab / 8 hs Diosmin ( 500mg) will be given from at  day of HCG injection and for 14 days."
            }, 
            {
                "arm_group_label": "Group B(Cabergoline  group)", 
                "arm_group_type": "Active Comparator", 
                "description": "while in group B (Cabergoline  group), 1 tab/day Cabergoline(Dostinex)( 0.5 mg) will be givenat  day of HCG injection till 8 days and for 14 days ."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the effect of oral Diosmin to oral Cabergoline in\n      the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women underwent\n      intracytoplasmic sperm injection (ICSI)."
        }, 
        "brief_title": "Prevention of Ovarian Hyperstimulation Syndrome", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": [
                "Infertility", 
                "Ovarian Hyperstimulation Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Two hundred women at risk of ovarian hyperstimulation syndrome during ICSI cycles will be\n      randomly scheduled into two equal groups. In group A, (Diosmin group),  2 tab / 8 hs Diosmin\n      ( 500mg) will be given  at  day of HCG injection and for 2 weeks ; while in group B\n      (Cabergoline  group), 1 tab/day Cabergoline( 0.5 mg) will be given at  day of HCG injection\n      and for 2 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: infertile women undergoing intracytoplasmic sperm injection or\n        polycystic ovarin syndrome (PCO) with one of the following:\n\n          1. Presence of more than 20 follicles by ultrasound\n\n          2. E2 more than 3000 pg/ml\n\n          3. Retrieval of more than 15 follicles\n\n        Exclusion Criteria:\n\n          -  none"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "48 Years", 
            "minimum_age": "23 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02134249", 
            "org_study_id": "khalid-ahmed"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group A (Diosmin group)", 
                "description": "2 tab / 8 hs Diosmin ( 500mg) will be given at  day of HCG injection till 8 days and for 14 days", 
                "intervention_name": "Diosmin", 
                "intervention_type": "Drug", 
                "other_name": "Daflon"
            }, 
            {
                "arm_group_label": "Group B(Cabergoline  group)", 
                "description": "1 tab/day Cabergoline( 0.5 mg) will be given at  day of HCG injection till 8 days and for 14 days", 
                "intervention_name": "Cabergoline", 
                "intervention_type": "Drug", 
                "other_name": "Dostinex"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Cabergoline"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "infertility", 
            "ICSI", 
            "OHSS", 
            "Diosmin", 
            "Cabergoline"
        ], 
        "lastchanged_date": "May 8, 2014", 
        "location": {
            "contact": {
                "email": "dr.khalidkhader77@yahoo.com", 
                "last_name": "khalid mohamed", 
                "phone": "201281469651"
            }, 
            "facility": {
                "address": {
                    "city": "Benha", 
                    "country": "Egypt", 
                    "state": "El Qualyobia", 
                    "zip": "13518"
                }, 
                "name": "Benha univesity hospital"
            }, 
            "investigator": {
                "last_name": "ahmed samy, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome", 
        "overall_contact": {
            "email": "dr.khalidkhader77@yahoo.com", 
            "last_name": "khalid mohamed", 
            "phone": "201281469651"
        }, 
        "overall_official": [
            {
                "affiliation": "Department of Obstetrics and Gynecology, Benha University Hospital", 
                "last_name": "khalid mohamed, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Obstetrics and Gynecology, Benha University Hospital", 
                "last_name": "ahmed samy, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Higher Education", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "this will be assessed by:\nClinically:\nAbdominal bloating\nMild abdominal pain\nNausea \u00b1 vomiting\nOliguria\nAcute respiratory distress syndrome\nBy ultrasound\nOvarian size usually \u02c38 cm\nUltrasound evidence of ascites\nLaboratory\nHaemoconcentration haematocrit \u02c345%\nHypoproteinaemia", 
            "measure": "ovarian hyperstimulation syndrome (OHSS)", 
            "safety_issue": "Yes", 
            "time_frame": "every two weeks for eight weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02134249"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Benha University", 
            "investigator_full_name": "khalid abd aziz mohamed", 
            "investigator_title": "lecturer of ob/gyn", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "\u03b2-hCG (serum hCG test) will be checked 16 days after embryos transfer", 
            "measure": "pregnancy rate", 
            "safety_issue": "Yes", 
            "time_frame": "16 days after embryos transfer"
        }, 
        "source": "Benha University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Benha University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}